Chuck writes:
Dear Daniel and Vincent,
Received a mRna boost on September 20th. Exposed to Covid the 22nd (a friend visited with a slight cough. He had just returned from Europe-unmasked on planes and terminals). SXS the 25th-neg home test. Positive test the 26th. Paxlovid the 27th.
Question 1. How does getting Covid so soon after the shot effect my immunity? This is my first bout of Covid.
Question 2. I am a 74 year old aerobic athlete. How should I approach return to activity? Writing on day 26 after positive test. Still a bit tired with slight cold symptoms.
Have not missed a show in 2.5 years. You guys are the best.
Thanks,
Chuck
Lori writes:
Hello Daniel and Vincent,
In your Oct 17th episode you mentioned a result from a study found that multiple boosters significantly reduced long term symptoms by 30-70%. I am assuming it means that multiple boosters before LC symptoms will reduce LC not that getting boosters once you have LC will reduce ones LC symptoms. Please clarify.
Best regards,
Lori
Robert writes:
Dr. Griffin,
A long time listener and advocate for science- please tell me how a clinician (Midwestern Doctor) gets to this point! It’s quite frightening to see this type of rhetoric. Thank you for all you and the microbe team do to keep us safe.
Kind regards,
Robert
David writes:
In late August, I did suffer Covid and was quickly treated with PAXLOVID with quick resolution of symptoms. I will be traveling to Chicago for Thanksgiving and I was wondering if I should get my next dose of vaccine two weeks prior to this trip or should I wait till December?
Thank you for your advice.
David Shulan, MD
Connor writes:
Dr. Griffin,
Thanks so much for your continued clinical updates. I have been enjoying them, as well as regular TWiV episodes for a number of years, even before I worked in healthcare.
I am a nurse in the ED at a community hospital connected to a large academic institution in the South. I’m coming up on finishing my first year as an RN, and I have been rather disheartened by the overwhelming reluctance of providers to prescribe Paxlovid for COVID patients. There’s always some sort of rationale from the provider when asked about it: “This patient is not high risk”; “Oh, it’s too expensive”; “But the rebound is not worth it”. I have tried before to suggest that the data actually suggests that these drawbacks to Paxlovid are overblown, especially with providers who know that prior to being a nurse I worked as a masters trained chemist, but I’m always told that Paxlovid is really just not good. Do you have any recommendations for advocating for a change in practice, especially for a new nurse interacting with seasoned providers?
Thank you,Connor